Showing 2911-2920 of 3223 results for "".
- LambdaVision Wins NASA Award to Further Advance Development of an Artificial Retinahttps://modernod.com/news/lambdavision-wins-nasa-award-to-further-advance-development-of-an-artificial-retina/2477556/LambdaVision, along with implementation partner, Space Tango, has been selected by NASA for an award of $5 million. This new funding will support LambdaVision’s development of the first protein-based artificial retina to restore meaningful vision for patients who are blind or have lost significan
- Apply for the SBA Paycheck Protection Programhttps://modernod.com/news/apply-for-the-sba-paycheck-protection-program/2477546/The Paycheck Protection Program (PPP) is a loan designed to provide a direct incentive for small businesses to keep their workers on the payroll. SBA will forgive loans if all employees are kept on the payroll for 8 weeks and the money is used for payroll, rent, mortgage interest, or utilities.</
- Experts Provide Update on Medicare Waivers and Other Regulatory Provisions During COVID-19https://modernod.com/news/experts-provide-update-on-medicare-waivers-and-other-regulatory-provisions-during-covid-19/2479527/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, spoke with Allison Shuren, JD, MSN; Paul Rudolf, MD, JD; and Thomas Gustafson, PhD, to discuss a variety of regulatory topic
- GlaxoSmithKline Takes $250 Million Stake in Vir as Companies Pair Up to Develop Coronavirus Treatmentshttps://modernod.com/news/glaxosmithkline-takes-250-million-stake-in-vir-as-companies-pair-up-to-develop-coronavirus-treatments/2477536/GlaxoSmithKline and Vir Biotechnology announced that they have agreed to enter into a collaboration to develop anti-viral antibodies for coronaviruses, including SARS-CoV-2. In addition, to gain access to Vir’s monoclonal antibody technology, GlaxoSmithKline said it will also make an equity
- Incyte, Novartis to Evaluate JAK Inhibitor Ruxolitinib for Severe COVID-19 Patientshttps://modernod.com/news/incyte-novartis-to-evaluate-jak-inhibitor-ruxolitinib-for-severe-covid-19-patients/2477527/Incyte and Novartis announced that the companies plan to initiate a phase 3 collaborative study to assess ruxolitinib plus standard-of-care, versus standard care alone, in patients suffering from COVID-19-associated cytokine storm. The clinical trial will be sponsored by Incyte in the US, where t
- BVI Donating Personal Protective Equipment to Help Protect the COVID-19 Frontlinehttps://modernod.com/news/bvi-donating-personal-protective-equipment-to-help-protect-the-covid-19-frontline/2477520/In a statement posted on its website, BVI stated that it is repurposing its products and redirecting supplies toward the COVID-19 response. It is also donating personal protective equipment (PPE) to health care facilities in hard hit areas. The statement reads: “COVID-19 is im
- FDA Calls for Withdrawal of Ranitidine Products as Review Finds Contaminant Could Pose Riskhttps://modernod.com/news/fda-calls-for-withdrawal-of-ranitidine-products-as-review-finds-contaminant-could-pose-risk/2477519/The FDA requested that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market, saying new evidence indicates users could be exposed to “unacceptable levels” of the probable carcinogen N-nitrosodimethylamine (NDMA) over time under ce
- Retina Industry Giants Temporarily Extend Payment Termshttps://modernod.com/news/retina-industry-giants-temporarily-extend-payment-terms/2477512/Genentech, Regeneron, Allergan, and Novartis are extending payment terms in response to the COVID-19 crisis. George Williams, MD, discussed the terms of extended payment by Genentech and Regeneron on a recent episode of New Retina Radio, and the details were confirmed by statements from th
- FDA Launches Program to Speed Development of COVID-19 Treatmentshttps://modernod.com/news/fda-launches-program-to-speed-development-of-covid-19-treatments/2477511/The FDA unveiled a new initiative, dubbed the “Coronavirus Treatment Acceleration Programme (CTAP),” designed to expedite the development of effective treatments for patients with COVID-19. Alex Azar, secretary of the US Department of Health and Human Services, said that “as par
- Tatsuya Kaihara Appointed CEO of Santen Inc. and Head of North America Business of Santen Pharmaceuticalhttps://modernod.com/news/tatsuya-kaihara-appointed-ceo-of-santen-inc-and-head-of-north-america-business-of-santen-pharmaceutical/2477510/Santen announced the appointment of Tatsuya Kaihara as Corporate Officer and Head of North America Business of Santen Pharmaceutical. As of April 1, he is also appointed as CEO of Santen Inc. and he will lead the company’s North America business and report to Shigeo Taniuchi, P